Ginkgo Bioworks Holdings, Inc.
DNA · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$80,755 | -$60,300 | -$90,957 | -$107,534 |
| Dep. & Amort. | $14,168 | $15,793 | $15,366 | $15,652 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $17,841 | $22,247 | $20,431 | $20,561 |
| Change in WC | $13,777 | -$22,713 | -$11,565 | $2,179 |
| Other Non-Cash | $3,363 | $4,719 | $15,204 | $26,707 |
| Operating Cash Flow | -$31,606 | -$40,254 | -$51,521 | -$42,435 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$38 | -$7,622 | -$13,710 |
| Net Acquisitions | $0 | $0 | $0 | $57 |
| Inv. Purchases | -$81,706 | -$128,950 | -$191,182 | $0 |
| Inv. Sales/Matur. | $8,641 | $64,958 | $0 | $568 |
| Other Inv. Act. | $249 | $142 | $120 | $0 |
| Investing Cash Flow | -$72,816 | -$63,888 | -$198,684 | -$13,085 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$24 | -$98 | -$207 | -$203 |
| Stock Issued | $0 | $0 | $0 | -$4 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,962 | $0 | $0 | $4 |
| Financing Cash Flow | $9,938 | -$98 | -$207 | -$203 |
| Forex Effect | $93 | -$1,608 | $74 | -$73 |
| Net Chg. in Cash | -$94,391 | -$105,848 | -$250,338 | -$55,796 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $251,351 | $320,363 | $605,743 | $661,539 |
| End Cash | $156,960 | $214,515 | $355,405 | $605,743 |
| Free Cash Flow | -$31,606 | -$40,292 | -$59,143 | -$56,145 |